Collateral for a security interest recorded Oct 2, 2019 (Encina Business Credit, LLC).
Term ends Jun 28, 2032 · High confidence
20-year base term ends Jun 28, 2032
Held by Neos Therapeutics, LP
Filed Mar 15, 2013 as application 13/844,584 · Granted Jul 7, 2015
Base term, 20 years from filing
Today
2012
2032
Clock starts
Jun 28, 2012
Jun 28, 2012
Term ends
Jun 28, 2032
Jun 28, 2032
Granted
Jul 7, 2015
Jul 7, 2015
base term
fee events
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
No effect
Terminal disclaimer
Resolved from the filed document, referencing US 9,089,496, to Jun 28, 2032. The term already ends on or before that date, so the cap shortened nothing.
2 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
11
Family applications on record here
Applications sharing this one's continuity chain, as the file histories and patent records this site holds name them. The family may have others.
This patent's term is its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer is resolved from the filed document, and it ends no earlier than this term, so it shortens nothing. 2 of 3 maintenance fees are paid so far. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Jun 28, 2012, when application PCT/US2012/044698, the earliest non-provisional in its chain, was filed (this one was filed Mar 15, 2013) | Jun 28, 2032 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 9,089,496) | resolves to Jun 28, 2032, no earlier than this term, so no change | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 2 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Jun 28, 2032 | High confidence |
This family
| Application PCT/US2012/044698 | PCT application no patent term | no patent term |
| Application 13/844,510 | Abandoned not computed | not computed |
| US 9,017,731 | In force Jun 2032 | Jun 2032 |
| US 9,839,619 | In force Jun 2032 | Jun 2032 |
| US 9,072,680 | this patent Jun 2032 | Jun 2032 |
| Application 13/844,628 | Abandoned not computed | not computed |
| Application 13/947,861 | Abandoned not computed | not computed |
| US 8,709,491 | In force Jun 2032 | Jun 2032 |
8 of 11 applications in this family shown, earliest filings first. Every application listed has its file history here. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Feb 18, 2014 Reel 32237, frame 347 | Tengler, Mark; McMahen, Russell | Neos Therapeutics, LP | Assignment of Assignor's Interest |
| Jun 15, 2016 Reel 38918, frame 965 | Neos Therapeutics, LP | Deerfield MGMT, L.P., as Collateral Agent | Security Interest |
| Oct 2, 2019 Reel 50606, frame 96 | Neos Therapeutics, LP | Encina Business Credit, LLC, as Agent | Security Interest |
| Oct 7, 2019 Reel 50638, frame 952 | Neos Therapeutics, LP | Deerfield MGMT, L.P., as Collateral Agent | Security Interest |
| Jan 28, 2022 Reel 58814, frame 437 | Deerfield Mgmt, L.p. | Neos Therapeutics, LP | Release of Security Interest |
| Feb 10, 2022 Reel 58977, frame 69 | Neos Therapeutics, LP | Avenue Venture Opportunities Fund II, L.P. | Security Interest |
| Mar 12, 2024 Reel 66725, frame 43 | Deerfield Mgmt, L.p. | Neos Therapeutics, LP | Release of Security Interest |
| Jun 14, 2024 Reel 67728, frame 327 | Avenue Venture Opportunities Fund, L.P. | Neos Therapeutics, LP | Release of Security Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
What's changing
Jun 2032
Term ends Jun 28, 2032. Maintenance fees still fall due before then
Terminal disclaimer
A terminal disclaimer resolved from the filed document, referencing US 9,089,496, ends no earlier than this term, so it caps nothing.
Citations
50
later US patents cite this one
That is top 10% of utility patents granted in 2015 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.